🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

#apaperaday Today’s pick is from Raguraman et al in MDPI Cancer on oligonucleotide mediated splice switching as Cancer therapy. From RakeshVeedu group. Fun fact: Rakesh and I generally meet in India when we are there for meetings (not necessarily the same ones).

A legend in DNA self-assembly and programmable DNA nanostructures. His wok is truly inspirational and I have read his wonderful papers with great interest and admiration. RIP Ned Seeman! nature.com/articles/d4158…

Looking for a Postdoctoral Scientist position in Perth, Australia? Please follow this link below for details; seek.com.au/job/55650967

Thank you Dr Tracey Wilkinson Caroline Duell Duncan and Team MTPConnect.

Look forward to speaking at the ‘Tech Trails in Tech Park 2022’ event today. Thank you to Town of Victoria Park, and the organising Team at SynGenis Pty Ltd Epichem and GeneS.

#HarmonyDay celebrations at #Syngenis. #DiversityandInclusion Read more: linkedin.com/feed/update/ur…

I am delighted to share this announcement from the Minister Hon Stephen Dawson MLC. I thank my wonderful team at Murdoch University @cmmit_mu & Perron Institute mediastatements.wa.gov.au/Pages/McGowan/…

💡Dr Liz Dallimore (Argenica Therapeutics), A.Prof RakeshVeedu (SynGenis Pty Ltd), John Barrington AM (Artrya) & Prof. Peter Leedman (miReven P/L) discussed challenges and opportunities as healthcare #innovators. Session chaired by Dr Dr Tracey Wilkinson from @MTPConnect Science on the Swan

Post COVID travel chaos at San Francisco airport! Hours long queue for immigration & security clearance! Never seen in my life! And of course I missed my flight to San Diego! 😡 2hrs is not enough! give 4 hours for international entry & transiting through major American airports.

A/Prof Rakesh Veedu, CEO Steve Arnott and Prof Anthony Akkari are attending the BIO International Convention 2022 in San Diego, talking medical research, innovation and partnerships. #BIO2022

Fresh after lunch, the main MCCB session got to hear from RakeshVeedu about new oligonucleotide compounds to treat a number of diseases 🧬💊

Today CMMIT was under the microscope with Vice Chancellor Professor Andrew Deeks meeting group leaders & learning about our diverse collaborative research projects. Professor Deeks was joined by Professor Peter Davies, Interim Deputy Vice Chancellor of Research & Innovation.

Excellent opportunity for another PhD graduate with aptamer development skills to join our team, and be part of an exciting, commercially focused project! Murdoch University @cmmit_mu Perron Institute lnkd.in/gppEgFzj

Murdoch scientists, together with University of Colorado, have developed a new approach to precisely target the genes that cause rare and acquired diseases. This presents a big opportunity to address diseases which disproportionately affect children and adolescents. murdoch.edu.au/news/articles/…

Excited to introduce Thiomorpholinos (TMOs) as a new RNA Therapeutic platform, and share this news article about our recent work published in pnas. Thank you Team at Murdoch University/Perron Institute & the University of Colorado. murdoch.edu.au/news/articles/…

#apaperaday Today’s pick is oligonucleotide themed because the Oligonucleotide Therapeutics Society #OTS22 meeting starts today with an educational session and the next generation session and the welcome reception. The publication is from PNASNews by Le et al from RakeshVeedu group

In Vienna for TIDES Europe 22 to speak about our new and exciting developments! #TIDESEUROPE

Look forward to speaking at the Gordon conference (grc.org/nucleosides-nu…).

Associate Professor RakeshVeedu in the spotlight for the recent launch of ProGenis Pharmaceuticals. @cmmit_mu Murdoch University & Perron Institute are all very proud to have been involved with this groundbreaking research into type 2 #diabetes

I am honored. I am grateful to my mentors, colleagues, collaborators, and my family.